Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06796738 · ClinicalTrials.gov registry record · NA
Advancing Cervical Cancer Screening Through the Emergency Department - IIS
A NA study of Hpv and Cervical Cancers, sponsored by University of Rochester.
- Active
- Registry status
- NA
- Development phase
- 200
- Enrollment target
- 1
- Study location
NCT06796738 is a NA study of Hpv and Cervical Cancers that is active but no longer recruiting, run by University of Rochester. The registered enrollment target is 200 participants, below the 2,233-participant average among 24 other Hpv trials with a reported enrollment target (91% lower). The trial reports 1 study location across 1 state.
The verdict
NCT06796738, a NA study of Hpv and Cervical Cancers, is active but no longer recruiting, sponsored by University of Rochester.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 200 participants
- Enrollment target
- 1
- Study location
Study Summary
Cervical cancer screening in the Emergency Department
Conditions Studied
Interventions
- DIAGNOSTIC_TEST HPV testing
Study Locations (1)
New York
- University of Rochester - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2025-06-13 |
| Est. Completion | 2027-03-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06796738
The ClinicalTrials.gov registry entry for NCT06796738 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 200 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,233-participant average among 24 other Hpv trials with a reported enrollment target (91% lower). The listed sponsor is University of Rochester, which has 636 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Hpv appearing as the primary indexed condition, and to 1 intervention - of which HPV testing is the first listed.
NCT06796738 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.
Frequently Asked Questions
What is clinical trial NCT06796738 about?
NCT06796738 is a clinical study titled "Advancing Cervical Cancer Screening Through the Emergency Department - IIS". Cervical cancer screening in the Emergency Department
What is the current status of trial NCT06796738?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 200 participants. The study started on 2025-06-13. Estimated completion is 2027-03-01.
What conditions does trial NCT06796738 study?
This clinical trial studies the following conditions: Hpv, Cervical Cancers.
What interventions are being tested in trial NCT06796738?
The interventions under investigation include: HPV testing (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT06796738?
This trial is sponsored by University of Rochester, which has 636 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06796738 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hpv
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
PopSci CHW4CervixHealth
RECRUITING · NA
-
Stand Up 2 HPV: Standing Orders to Improve HPV Vaccination
RECRUITING · NA
-
HPV Self-Collection Program
RECRUITING · NA
-
Evaluation of the Q-Pad hrHPV Test System for Identifying Precancer
RECRUITING · NA
-
Prevención en Sus Manos: Feasibility of a Novel Community-Based Strategy to Improve Access to Cervical Cancer Screening
RECRUITING · NA
-
Playing Game to Learn About Children's Vaccine Project
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.